Tralokinumab Promising for Moderate-to-Severe Atopic Dermatitis: 28-Week Real-World Study Results Medha Baranwal31 Dec 2024 8:45 PM ISTNetherlands: A recent study demonstrated that tralokinumab is an effective treatment for moderate-to-severe atopic dermatitis in adult patients,...
Cendakimab effective, safe, and well-tolerated in patients with moderate to severe atopic dermatitis: JAMA Dr Riya Dave13 Aug 2024 8:30 AM ISTResearchers have found that cendakimab, an interleukin-13 (IL-13) targeting monoclonal antibody, significantly reduces the severity of atopic...
Obesity Linked to Increased severity of Atopic Dermatitis: Study Dr Riya Dave4 May 2024 12:45 AM ISTResearchers have found that obesity is associated with clinician- and patient-assessed severity of atopic dermatitis (AD), although the effect sizes...
